Showing results (341-350 of 380) with videos related to

Sort By:
Pageof 38
Annals of Hematology|February 9, 2000
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)A Ganser, G Heil, G Seipelt, et al.
Diabetes|May 5, 2026
The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover StudyNikolaj E Sørum, Julie Warnøe, Jens J Holst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2008
Market and patient access to new oncology products in Europe: a current, multidisciplinary perspectiveC McCabe, L Bergmann, N Bosanquet, et al.
The Journal of Nutrition|June 4, 2025
High Plasma 18β-Glycyrrhetinic Acid Levels Are Associated With More Intensive Antihypertensive Treatment, Resistant Hypertension and Apparent Mineralocorticoid Excess in Patients With Type 2 DiabetesJakob L Wetche, Anne V Schmedes, Amalie Sjøgren, et al.
Environmental Pollution (Barking, Essex : 1987)|August 18, 2023
Short-term exposure to ultrafine particles and mortality and hospital admissions due to respiratory and cardiovascular diseases in Copenhagen, DenmarkMarie L Bergmann, Zorana J Andersen, Andreas Massling, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIVL Bergmann, L Maute, G Heil, et al.
Blood|July 27, 2001
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II studyD Bunjes, I Buchmann, C Duncker, et al.
Annals of Hematology|May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemiaW K Hofmann, G Heil, C Zander, et al.
The Journal of Allergy and Clinical Immunology|July 31, 2012
Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay feverLaura Hatzler, Valentina Panetta, Susanne Lau, et al.
British Journal of Pharmacology|August 21, 2013
The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptorsK Hoestgaard-Jensen, R M O'Connor, N O Dalby, et al.
Pageof 38